
[Federal Register: June 25, 2010 (Volume 75, Number 122)]
[Notices]               
[Page 36432]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25jn10-83]                         


[[Page 36432]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-N-0001]

 
Tobacco Products Scientific Advisory Committee; Amendment of 
Notice

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the Tobacco Products Scientific Advisory 
Committee. This meeting was announced in the Federal Register of May 
19, 2010 (75 FR 28027). The amendment is being made to reflect a change 
in the Agenda and Procedure portions of the document. The Agenda 
portion is changed to cancel Topic 1 regarding dissolvable tobacco 
products. This portion of the meeting has been cancelled. The Procedure 
portion is changed to a 1-hour open public hearing from 10 a.m. to 11 
a.m. on July 16, 2010. There are no other changes.

FOR FURTHER INFORMATION CONTACT: Cristi Stark, Center for Tobacco 
Products, Food and Drug Administration, 9200 Corporate Blvd, Rockville, 
MD 20850, 1-877-287-1373 (choose Option 4), e-mail: TPSAC@fda.hhs.gov 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington DC area), code 8732110002. Please call the 
Information Line for up-to-date information on this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of May 19, 2010 (75 
FR 28027), FDA announced that a meeting of the Tobacco Products 
Scientific Advisory Committee would be held on July 15 and 16, 2010. On 
page 28027, in the first column, the Agenda portion of the document is 
changed to read as follows:
    Agenda: On July 15, 2010, the committee will: (1) Receive updates 
on upcoming committee business related to menthol, including Agency 
requests for information from industry on menthol cigarettes in order 
to prepare for the Tobacco Products Scientific Advisory Committee's 
required report to the Secretary of Health and Human Services regarding 
the impact of use of menthol in cigarettes on the public health and (2) 
hear and discuss industry presentations on menthol in cigarettes as 
they relate to the following five topics: Characterization of menthol, 
clinical effects of menthol, biomarkers of disease risk, marketing 
data, and population effects.
    On page 28027, in the third column, the Agenda portion of the 
document is changed to read as follows:
    Agenda: On July 16, 2010, the committee will continue discussion on 
topic 2.
    On page 28028, in the first column, the Procedure portion of the 
document is changed to read as follows:
    Procedure: Oral presentations from the public (excluding the 
tobacco industry) will be scheduled between approximately 10 a.m. and 
11 a.m. on July 16, 2010.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

    Dated: June 22, 2010.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-15554 Filed 6-23-10; 11:15 am]
BILLING CODE 4160-01-S

